A recent study using double-labeling and mutually exclusive Ki-67 and BCL-2 dynamic markers demonstrated that AML blast cells simultaneously showed increased antiapoptotic and reduced proliferative marker expression [66]. Here, BCL2 is linked to acute myeloid leukemia.